NPC
CRMD icon

National Planning Corporation’s CorMedix CRMD Stock Holding History

National Planning Corporation’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-200
Closed -$1.92K – 913
2014
Q4 		$1.92K Buy
+200
New +$1.59K ﹤0.01% 2588

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

National Planning Corporation's CRMD Position: Q1 2015 in Review

National Planning Corporation sold out of CorMedix (CRMD) in Q1 2015, closing a stake of 200 shares — an estimated $1.92K sold.

National Planning Corporation first reported a position in CRMD in Q4 2014 and held it in 1 quarter. The position peaked at $1.92K in Q4 2014. 31 funds tracked by Wall St. Rank hold CRMD as of Q1 2015.

  • National Planning Corporation reported no remaining CorMedix position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 200 CorMedix shares in Q1 2015, an estimated $1.92K.
  • National Planning Corporation first reported a position in CorMedix in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's CorMedix position peaked at $1.92K in Q4 2014.
  • 31 funds tracked by Wall St. Rank held CorMedix as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.